Literature DB >> 17408445

Successful treatment with cyclosporin administration for persistent benign migratory glossitis.

Masatoshi Abe1, Yoko Sogabe, Tomoko Syuto, Hirohisa Ishibuchi, Yoko Yokoyama, Osamu Ishikawa.   

Abstract

We herein describe a 54 year-old female patient with a 5-year history of persistent and painful benign migratory glossitis (BMG), which was remarkably improved by systemic administration of cyclosporin. She had noted some white patches leaving smooth denuded red areas with whitish elevated borders on the dorsum of her tongue, and finally felt strong pain. The lesion was refractory to the previous treatment with topical corticosteroid treatment for the last 2 years. Because clinicopathological findings were compatible with BMG, systemic administration of 20 mg/day prednisolone and topical 0.1% dexamethasone application were started, however, she suffered a severe relapse after tapering the dosage of prednisolone to 10 mg/day. Because some investigations have suggested that BMG is an oral manifestation of psoriasis, we introduced cyclosporin administration. The systemic treatment of cyclosporin microemulsion pre-concentrate, 3 mg/kg/day, resulted in a satisfactory improvement. Two months later, we could reduce cyclosporin microemulsion pre-concentrate dosage to 1.5 mg/kg/day for maintenance therapy, and the disease has been well controlled so far.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17408445     DOI: 10.1111/j.1346-8138.2007.00284.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  9 in total

1.  Characteristics of oral mucosal events related to bevacizumab treatment.

Authors:  Igor T Gavrilovic; Yevgeniy Balagula; Alyx C Rosen; Vijay Ramaswamy; Maura N Dickler; Ira J Dunkel; Mario E Lacouture
Journal:  Oncologist       Date:  2012-01-26

2.  Geographic tongue treated with topical tacrolimus.

Authors:  Masaya Ishibashi; Genichi Tojo; Masahiko Watanabe; Takahiro Tamabuchi; Takashi Masu; Setsuya Aiba
Journal:  J Dermatol Case Rep       Date:  2010-12-31

3.  Geographic tongue in monozygotic twins.

Authors:  Guna Shekhar M
Journal:  J Clin Diagn Res       Date:  2014-04-15

4.  Treatment of symptomatic benign migratory glossitis: a systematic review.

Authors:  Wladimir Gushiken de Campos; Camila Vieira Esteves; Lígia Gonzaga Fernandes; Carina Domaneschi; Celso Augusto Lemos Júnior
Journal:  Clin Oral Investig       Date:  2018-07-07       Impact factor: 3.573

Review 5.  Paediatric Geographic Tongue: A Case Report, Review and Recent Updates.

Authors:  Doddabasavaiah Basavapur Nandini; Shivanand Bagalad Bhavana; Byathnal Suryakanth Deepak; Ramakrishna Ashwini
Journal:  J Clin Diagn Res       Date:  2016-02-01

6.  Treatment of Symptomatic Geographic Tongue with Triamcinolone Acetonide Alone and in Combination with Retinoic Acid: A Randomized Clinical Trial.

Authors:  Shamsoulmolouk Najafi; Narges Gholizadeh; Elahe Akhavan Rezayat; Mohammad Javad Kharrazifard
Journal:  J Dent (Tehran)       Date:  2016-01

7.  Characterization of sensory neuronal subtypes innervating mouse tongue.

Authors:  Ping Wu; Dominic Arris; Max Grayson; Chia-Nung Hung; Shivani Ruparel
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

Review 8.  Geographic tongue and psoriasis: clinical, histopathological, immunohistochemical and genetic correlation - a literature review.

Authors:  Bruna Lavinas Sayed Picciani; Tábata Alves Domingos; Thays Teixeira-Souza; Vanessa de Carla Batista Dos Santos; Heron Fernando de Sousa Gonzaga; Juliana Cardoso-Oliveira; Alexandre Carlos Gripp; Eliane Pedra Dias; Sueli Carneiro
Journal:  An Bras Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.896

9.  Evaluation of the Th17 pathway in psoriasis and geographic tongue.

Authors:  Bruna Lavinas Sayed Picciani; Tábata Alves Domingos; Thays Teixeira-Souza; Anna Karoline Fausto-Silva; Eliane Pedra Dias; Sueli Carneiro
Journal:  An Bras Dermatol       Date:  2019-10-24       Impact factor: 1.896

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.